KA
LH icon

Kozak & Associates’s Labcorp LH Stock Holding History

Kozak & Associates’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-17
Closed -$3.18K – 405
2023
Q2 		$3.18K Hold
17
– – ﹤0.01% 289
2023
Q1 		$3.48K Hold
17
– – ﹤0.01% 281
2022
Q4 		$4K Hold
17
– – ﹤0.01% 279
2022
Q3 		$3K Hold
17
– – ﹤0.01% 284
2022
Q2 		$4K Hold
17
– – ﹤0.01% 306
2022
Q1 		$4K Hold
17
– – ﹤0.01% 325
2021
Q4 		$4K Hold
17
– – ﹤0.01% 325
2021
Q3 		$4K Buy
+17
New +$4.28K ﹤0.01% 286

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kozak & Associates's LH Position: Q3 2023 in Review

Kozak & Associates sold out of Labcorp (LH) in Q3 2023, closing a stake of 17 shares — an estimated $3.18K sold.

Kozak & Associates first reported a position in LH in Q3 2021 and held it in 8 quarters. The position peaked at $4K in Q4 2022. 881 funds tracked by Wall St. Rank hold LH as of Q3 2023.

  • Kozak & Associates reported no remaining Labcorp position as of Q3 2023 after selling out during the quarter.
  • Kozak & Associates sold 17 Labcorp shares in Q3 2023, an estimated $3.18K.
  • Kozak & Associates first reported a position in Labcorp in Q3 2021 and held it in 8 quarters.
  • Kozak & Associates's Labcorp position peaked at $4K in Q4 2022.
  • 881 funds tracked by Wall St. Rank held Labcorp as of Q3 2023.

Based on Kozak & Associates's 13F filing for Q3 2023, filed 17 Oct 2023.